Henry J. Fuchs, President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 15,000 shares at $90.00 ($1.4M) on 2017-06-16, disclosed to the SEC on 2017-06-20.
Seasonal sale ($1.4M) by President, Worldwide R&D — this insider has traded BMRN in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.00 | 5,000 | $450K | 33.3% |
| 2 | $90.00 | 9,397 | $846K | 62.6% |
| 3 | $90.00 | 603 | $54K | 4.0% |
| Total | $90.00 avg | 15,000 | $1.4M | 100% |
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |